{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T20:01:09Z","timestamp":1780344069219,"version":"3.54.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30-CA-51008"],"award-info":[{"award-number":["P30-CA-51008"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Endowed Jess and Mildred Fisher Center for Hereditary Cancer and Clinical Genomics Research"},{"name":"Endowed Jess and Mildred Fisher Center for Hereditary Cancer and Clinical Genomics Research"},{"DOI":"10.13039\/100004328","name":"Genentech","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004328","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1007\/s10549-015-3527-8","type":"journal-article","created":{"date-parts":[[2015,8,6]],"date-time":"2015-08-06T10:55:28Z","timestamp":1438858528000},"page":"201-209","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Deleterious BRCA1\/2 mutations in an urban population of Black women"],"prefix":"10.1007","volume":"153","author":[{"given":"Filipa","family":"Lynce","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen Lisa","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Stein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiffani","family":"DeMarco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiru","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongkun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Fries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beth N.","family":"Peshkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudine","family":"Isaacs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,8,7]]},"reference":[{"issue":"9","key":"3527_CR1","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1002\/cncr.22618","volume":"109","author":"KR Bauer","year":"2007","unstructured":"Bauer KR, Brown M, Cress RD (2007) Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study from the California cancer Registry. Cancer 109(9):1721\u20131728","journal-title":"Cancer"},{"issue":"3","key":"3527_CR2","doi-asserted-by":"publisher","first-page":"R31","DOI":"10.1186\/bcr2261","volume":"11","author":"ML Kwan","year":"2009","unstructured":"Kwan ML, Kushi LH, Weltzien E et al (2009) Epidemiology of breast cancer subtypes in two prospective cohort studies of breast cancer survivors. Breast Cancer Res 11(3):R31. doi:\n                    10.1186\/bcr2261","journal-title":"Breast Cancer Res"},{"issue":"1\u20132","key":"3527_CR3","first-page":"25","volume":"32","author":"BN Peshkin","year":"2010","unstructured":"Peshkin BN, Alabek ML, Isaacs C (2010) BRCA1\/2 mutations and triple negative breast cancers. Breast Dis 32(1\u20132):25\u201333","journal-title":"Breast Dis"},{"key":"3527_CR4","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/1471-2407-9-86","volume":"9","author":"SR Young","year":"2009","unstructured":"Young SR, Pilarski RT, Donenberg T et al (2009) The prevalence of BRCA1 mutations among young women with triple-negative breast cancer. BMC Cancer 9:86. doi:\n                    10.1186\/1471-2407-9-86","journal-title":"BMC Cancer"},{"key":"3527_CR5","doi-asserted-by":"publisher","first-page":"4282","DOI":"10.1200\/JCO.2008.16.6231","volume":"26","author":"DP Atchley","year":"2008","unstructured":"Atchley DP, Albarracin CT, Lopez A et al (2008) Clinical and pathologic characteristics of patients with BRCA-positive and BRCA-negative breast cancer. J Clin Oncol 26:4282\u20134288","journal-title":"J Clin Oncol"},{"key":"3527_CR6","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1200\/JCO.2014.57.1414","volume":"33","author":"FJ Couch","year":"2015","unstructured":"Couch FJ, Hart SN, Sharma P et al (2015) Inherited mutations in 17 breast cancer susceptibility genes among a large triple-negative breast cancer cohort unselected for family history of breast cancer. J Clin Oncol 33:304\u2013311","journal-title":"J Clin Oncol"},{"issue":"2","key":"3527_CR7","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1023\/A:1023006000760","volume":"14","author":"MD Althuis","year":"2003","unstructured":"Althuis MD, Brogan DD, Coates RJ (2003) Breast cancers among very young premenopausal women (United States). Cancer Causes Control 14(2):151\u2013160","journal-title":"Cancer Causes Control"},{"issue":"2","key":"3527_CR8","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1111\/tbj.12083","volume":"19","author":"T Pal","year":"2013","unstructured":"Pal T, Bonner D, Kim J et al (2013) Early onset Breast Cancer in a Registry-based sample of African-American women: BRCA mutation prevalence, and other personal and system-level clinical characteristics. Breast J 19(2):189\u2013192","journal-title":"Breast J"},{"issue":"24","key":"3527_CR9","doi-asserted-by":"publisher","first-page":"2869","DOI":"10.1001\/jama.298.24.2869","volume":"298","author":"EM John","year":"2007","unstructured":"John EM, Miron A, Gong G et al (2007) Prevalence of pathogenic BRCA1 mutation carriers in 5 U.S. racial\/ethnic groups. JAMA 298(24):2869\u20132876","journal-title":"JAMA"},{"issue":"16","key":"3527_CR10","doi-asserted-by":"publisher","first-page":"8297","DOI":"10.1158\/0008-5472.CAN-06-0503","volume":"66","author":"KE Malone","year":"2006","unstructured":"Malone KE, Daling JR, Doody DR et al (2006) Prevalence and predictors of BRCA1 and BRCA2 mutations in a population-based study of breast cancer in white and black American women ages 35 to 64 years. Cancer Res 66(16):8297\u20138308","journal-title":"Cancer Res"},{"key":"3527_CR11","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1136\/jmg.2005.034744","volume":"43","author":"BG Haffty","year":"2006","unstructured":"Haffty BG, Silber A, Matloff E et al (2006) Racial differences in the incidence of BRCA1 and BRCA2 mutations in a cohort of early onset breast cancer patients: African American compared to white women. J Med Genet 43:133\u2013137","journal-title":"J Med Genet"},{"issue":"15","key":"3527_CR12","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1001\/jama.294.15.1925","volume":"294","author":"R Nanda","year":"2005","unstructured":"Nanda R, Schumm LP, Cummings S et al (2005) Genetic testing in an ethnically diverse cohort of high-risk women: a comparative analysis of BRCA1 and BRCA2 mutations in American families of European and African ancestry. JAMA 294(15):1925\u20131933","journal-title":"JAMA"},{"issue":"10","key":"3527_CR13","doi-asserted-by":"publisher","first-page":"2222","DOI":"10.1002\/cncr.24200","volume":"115","author":"MJ Hall","year":"2009","unstructured":"Hall MJ, Reid JE, Burbidge LA et al (2009) BRCA1 and BRCA2 mutations in women of different ethnicities undergoing testing for hereditary breast-ovarian cancer. Cancer 115(10):2222\u20132233","journal-title":"Cancer"},{"issue":"21","key":"3527_CR14","doi-asserted-by":"publisher","first-page":"5210","DOI":"10.1002\/cncr.27556","volume":"118","author":"T Judkins","year":"2012","unstructured":"Judkins T, Rosenthal E, Arnell C et al (2012) Clinical significance of large rearrangements in BRCA1 and BRCA2. Cancer 118(21):5210\u20135216","journal-title":"Cancer"},{"issue":"10","key":"3527_CR15","doi-asserted-by":"publisher","first-page":"3254","DOI":"10.1245\/s10434-013-3205-1","volume":"20","author":"R Greenup","year":"2013","unstructured":"Greenup R, Buchanan A, Lorizio W et al (2013) Prevalence of BRCA mutations among women with triple-negative breast cancer (TNBC) in a genetic counseling cohort. Ann Surg Oncol 20(10):3254\u20133258","journal-title":"Ann Surg Oncol"},{"key":"3527_CR16","unstructured":"National Comprehensive Cancer Network Inc. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines\u00ae). Genetic\/Familial High-Risk Assessment: Breast and Ovarian. Version 2.2015. \n                    www.nccn.org\/professionals\/physician_gls\/pdf\/genetics_screening.pdf\n                    \n                  , Accessed 8 July 2015"},{"key":"3527_CR17","unstructured":"Stuckey A, Febbraro T, Laprise J, et al (2014) Adherence patterns to National Comprehensive Cancer Network Guidelines for referral of women with breast cancer to genetics professionals. Am J Clin Oncol 2014 [Epub ahead of print]"},{"issue":"2","key":"3527_CR18","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/s12687-013-0166-9","volume":"5","author":"T Pal","year":"2014","unstructured":"Pal T, Bonner D, Cragun D et al (2014) BRCA sequencing and large rearrangement testing in young Black women with breast cancer. J Commun Genet 5(2):157\u2013165","journal-title":"J Commun Genet"},{"issue":"5","key":"3527_CR19","first-page":"1021","volume":"60","author":"D Stoppa-Lyonnet","year":"1997","unstructured":"Stoppa-Lyonnet D, Laurent-Puig P, Essioux L et al (1997) BRCA1 sequence variations in 160 individuals referred to a breast\/ovarian family cancer clinic. Institut Curie Breast Cancer Group. Am J Hum Genet 60(5):1021\u20131030","journal-title":"Am J Hum Genet"},{"key":"3527_CR20","doi-asserted-by":"crossref","unstructured":"Shatavi SV, Dohany, L, Chisti MM, et al. (2013) Unique genetic characteristics of BRCA mutation carriers in a cohort of Arab American women. J Clin Oncol 31, (suppl;aabstr 1541)","DOI":"10.1200\/jco.2013.31.15_suppl.1541"},{"key":"3527_CR21","unstructured":"Eggington JM, Burbidge LA, Roa B, et al (2012) Current variant of uncertain significance rates in BRCA1\/2 and Lynch syndrome testing (MLH1, MSH2, MSH6, PMS2, EPCAM) American College of Medical Genetics and Genomics annual meeting, Charlotte"},{"key":"3527_CR22","unstructured":"Ricker CN, Sturgeon JD, Gruber SB (2014) Mutation and uncertain variant findings in ethnic minority patients undergoing multi-gene panel testing for cancer risk assessment at a safety-net public hospital (Abstract 3428S). Presented at the 64th Annual Meeting of the American Society of Human Genetics, on October 2014 in San Diego"},{"issue":"11","key":"3527_CR23","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1038\/gim.2014.40","volume":"16","author":"H LaDuca","year":"2014","unstructured":"LaDuca H, Stuenkel AJ, Dolinsky JS et al (2014) Utilization of multigene panels in hereditary cancer predisposition testing: analysis of more than 2,000 patients. Gene Med 16(11):830\u2013837","journal-title":"Gene Med"},{"issue":"1","key":"3527_CR24","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1002\/cncr.29010","volume":"121","author":"N Tung","year":"2015","unstructured":"Tung N, Battelli C, Allen B et al (2015) Frequency of mutations in individuals with breast cancer referred for BRCA1 and BRCA2 testing using next-generation sequencing with a 25-gene panel. Cancer 121(1):25\u201333","journal-title":"Cancer"},{"issue":"2","key":"3527_CR25","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1002\/cncr.26294","volume":"118","author":"MD Schwartz","year":"2012","unstructured":"Schwartz MD, Isaacs C, Graves KD et al (2012) Long-term outcome of BRCA1\/BRCA2 testing: risk reduction and surveillance. Cancer 118(2):510\u2013517","journal-title":"Cancer"},{"key":"3527_CR26","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1097\/GIM.0b013e318163487d","volume":"10","author":"AR Bradbury","year":"2008","unstructured":"Bradbury AR, Comfort NI, Dignam JJ et al (2008) Uptake and timing of bilateral prophylactic salpingo-oophorectomy among BRCA1 and BRCA2 mutation carriers. Genet Med 10:161\u2013166","journal-title":"Genet Med"},{"key":"3527_CR27","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/s10897-006-9026-7","volume":"15","author":"AY Kinney","year":"2006","unstructured":"Kinney AY, Simonsen SE, Baty BJ (2006) Risk reduction behaviors and provider communication following genetic counseling and BRCA1 mutation testing in an African American kindred. J Genet Couns 15:293\u2013305","journal-title":"J Genet Couns"},{"key":"3527_CR28","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1111\/j.1525-1497.2006.00461.x","volume":"21","author":"T Salant","year":"2006","unstructured":"Salant T, Ganschow PS, Olopade OI (2006) \u201dWhy take it if you don\u2019t have anything?\u201d breast cancer risk perceptions and prevention choices at a public hospital. J Gen Intern Med 21:779\u2013785","journal-title":"J Gen Intern Med"},{"issue":"11","key":"3527_CR29","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1089\/gtmb.2012.0114","volume":"16","author":"HS Thompson","year":"2012","unstructured":"Thompson HS, Sussner K, Schwartz MD et al (2012) Receipt of genetic counseling recommendations among black women at high risk for BRCA mutations. Genet Test Molec Biomark 16(11):1257\u20131262","journal-title":"Genet Test Molec Biomark"},{"issue":"31","key":"3527_CR30","doi-asserted-by":"publisher","first-page":"7967","DOI":"10.1200\/JCO.2004.00.4952","volume":"23","author":"CH Halbert","year":"2005","unstructured":"Halbert CH, Brewster K, Collier A et al (2005) Recruiting African American women to participate in hereditary breast cancer research. J Clin Oncol 23(31):7967\u20137973","journal-title":"J Clin Oncol"},{"issue":"3","key":"3527_CR31","first-page":"267","volume":"22","author":"BA Glenn","year":"2012","unstructured":"Glenn BA, Chawla N, Bastani R (2012) Barriers to genetic testing for breast cancer risk among ethnic minority women: an exploratory study. Ethn Dis 22(3):267\u2013273","journal-title":"Ethn Dis"},{"key":"3527_CR32","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1200\/JCO.2007.10.6377","volume":"26","author":"LR Susswein","year":"2008","unstructured":"Susswein LR, Skrzynia C, Lange LA et al (2008) Increased uptake of BRCA1\/2 genetic testing among African American women with a recent diagnosis of breast cancer. J Clin Oncol 26:32\u201336","journal-title":"J Clin Oncol"},{"issue":"6","key":"3527_CR33","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1159\/000325263","volume":"14","author":"KM Sussner","year":"2011","unstructured":"Sussner KM, Edwards TA, Thompson HS et al (2011) Ethnic, racial and cultural identity and perceived benefits and barriers related to genetic testing for breast cancer among at-risk women of African descent in New York City. Public Health Genomics 14(6):356\u2013370","journal-title":"Public Health Genomics"},{"issue":"5","key":"3527_CR34","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1097\/MLR.0b013e31824d748b","volume":"50","author":"K Armstrong","year":"2012","unstructured":"Armstrong K, Putt M, Halbert CH et al (2012) The influence of health care policies and health care system disrupt on willingness to undergo genetic testing. Med Care 50(5):381\u2013387","journal-title":"Med Care"},{"key":"3527_CR35","unstructured":"Affordable Care Act Implementation FAQs\u2013Set 12. \n                    http:\/\/www.cms.gov\/CCIIO\/Resources\/Fact-Sheets-and-FAQs\/aca_implementation_faqs12.html\n                    \n                  . Accessed on April 15 2015"},{"issue":"1","key":"3527_CR36","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s10549-014-3195-0","volume":"149","author":"JE Churpek","year":"2015","unstructured":"Churpek JE, Walsh T, Zheng Y et al (2015) Inherited predispostion to breast cancer among African American women. Breast Cancer Res Treat 149(1):31\u201339","journal-title":"Breast Cancer Res Treat"},{"issue":"9","key":"3527_CR37","doi-asserted-by":"publisher","first-page":"3214","DOI":"10.1158\/1078-0432.CCR-08-3128","volume":"15","author":"T Heikkinen","year":"2009","unstructured":"Heikkinen T, K\u00e4rkk\u00e4inen H, Aaltonen K et al (2009) The breast cancer susceptibility mutation PALB2 1592delT is associated with an aggressive tumor phenotype. Clin Cancer Res 15(9):3214\u20133222","journal-title":"Clin Cancer Res"},{"issue":"6","key":"3527_CR38","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1056\/NEJMoa1400382","volume":"371","author":"AC Antoniou","year":"2014","unstructured":"Antoniou AC, Casadei S, Heikkinen T et al (2014) Breast-cancer risk in families with mutations in PALB2. N Engl J Med 371(6):497\u2013506","journal-title":"N Engl J Med"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-015-3527-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-015-3527-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-015-3527-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-015-3527-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,17]],"date-time":"2020-05-17T13:07:02Z","timestamp":1589720822000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-015-3527-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["3527"],"URL":"https:\/\/doi.org\/10.1007\/s10549-015-3527-8","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"28 May 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}